The Australian stock market recently experienced a solid performance, buoyed by higher gold and silver prices and a positive ...
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...
GlobalData on MSN
ImmunityBio’s Anktiva shows success as combo treatment in NSCLC
Anktiva plus checkpoint inhibitor therapy demonstrated statistically significant immune restoration across two clinical ...
Having someone to care about or feel excited for can change your body chemistry and improve your health more than you might ...
QUILT-3.055 is a basket trial evaluating nogapendekin alfa inbakicept across multiple solid tumor types. In the NSCLC cohort, patients received the agent via subcutaneous injection every three weeks ...
Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...
Novel research led by Brazilian scientists describes the immune system's reactions in detail in the first living patient to ...
Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Study Finds on MSN
What if your skin could warn you about disease before symptoms appear by glowing green?
Green means go…to the doctor In A Nutshell Scientists engineered living skin that glows green when it detects inflammation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback